Diagnosing rare genetic diseases can be a long and complicated process. Doctors and genetic experts rely on analyzing huge amounts of DNA data to find clues about these conditions. Even with advanced technology, less than half of initial cases get a clear diagnosis. Reanalyzing data can help uncover new insights, but it’s often slow and difficult. To tackle these issues, Microsoft Research has explored how artificial intelligence (AI) can assist specialists in making sense of complex genomic data more efficiently.

Understanding the Role of Whole Genome Sequencing

Many rare diseases affect millions of people worldwide, and getting a diagnosis can take years. Whole genome sequencing involves reading a person’s entire DNA to spot genetic variants that might cause disease. Experts compare a patient’s DNA to reference genomes to identify differences. They then filter through over a million variants using bioinformatics tools to find potential disease-causing changes. This process, called sensemaking, involves searching, filtering, and synthesizing data to build models of what might be going wrong at the genetic level.

However, sifting through all this information is a huge challenge. It requires a lot of time and expertise to interpret the data correctly. Even with the best tools, many cases remain unsolved. The complexity of the data and the volume of variants make it difficult to quickly reach a diagnosis. That’s where AI can step in to help streamline the process and support professionals in their work.

How AI Can Help Improve Diagnosis Workflows

Researchers are now exploring ways to use generative AI to assist genetic professionals. The idea is to create AI tools that can help synthesize biomedical data more quickly and accurately. By collaborating with AI, experts can analyze complex gene and variant information more efficiently. This partnership aims to increase the number of diagnoses for previously unsolved cases, ultimately helping patients receive faster and more accurate results.

Integrating AI into genetic workflows could significantly cut down the time it takes to analyze whole genome data. This means quicker diagnoses, better treatment plans, and improved quality of life for people with rare diseases. The research shows promising signs that AI can be a powerful ally in the fight against these complex conditions, helping to unlock answers that might otherwise remain hidden.

In summary, AI-assisted analysis has the potential to revolutionize how we diagnose rare genetic diseases. By addressing current challenges in data management and interpretation, AI can help genetic professionals work more efficiently. This advancement could lead to more timely diagnoses and better health outcomes for many patients around the world.

Inspired by

• https://www.microsoft.com/en-us/research/blog/using-ai-to-assist-in-rare-disease-diagnosis/

Sources

• acm.org
• azure.com
• biorxiv.org
• aka.ms